Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. Daiichi Sankyo, Inc.
EIR
•Daiichi Sankyo, Inc.•August 27, 2015

Daiichi Sankyo, Inc. – FDA EIR, Aug 27, 2015

Record Details

An FDA Pre-Approval and cGMP inspection was conducted at Daiichi Sankyo, Inc.'s Bethlehem, PA facility from August 24-27, 2015. This inspection, carried out under regulatory guidelines CP 7346.832 and CP 7356.002B, primarily evaluated the site's capability to perform stability testing for Tribenzor (NDA N200175/023), as it functions as a packaging facility. The review encompassed Quality, Laboratory, Facilities, and Packaging and Labeling Systems. While no formal FDA 483 Inspectional Observations were issued, the inspection revealed several verbal observations and issues. A notable concern was a consistent delay, ranging from 5 months to a year, in the Bethlehem site receiving complaint notifications from the corporate Quality Assurance department. Additionally, a specific shelf area within one stability chamber (STAB-001) did not meet required relative humidity specifications and was designated "not for cGMP use," necessitating remediation. The use of incorrect HPLC vials in the DSI Bethlehem laboratory also led to inaccurate dissolution results, a problem corrected by adopting certified screw-top vials. Further, the continuous monitoring system for the new stability laboratory's refrigerator/freezer units was noted as "not yet validated." Required actions for the firm include streamlining internal complaint notification processes, ensuring all stability chamber areas meet cGMP requirements, implementing stringent control over laboratory consumables like HPLC vials, validating laboratory monitoring systems, and enhancing new hire GMP training as agreed by management.

Company
Daiichi Sankyo, Inc.
Inspection date
August 27, 2015
Product type
drugs
Office
Division of Pharmaceutical Quality Operations I
People
  • Deborah J. Parris (investigator)
  • William Rieser (company_representative)
  • Halwyn Lewis (recipient)
  • Reginald C. Halton (recipient)
  • Monica Pena (company_representative)
View Company Profile

ID · 22d430fe-bfb8-4a10-a5ad-29cea2f568bc

Violation Codes1
21 CFR 820.100

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Daiichi Sankyo, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.